Twitter Linkedin
Search
Close
Twitter Linkedin
Search
Close
  • Home
  • About
    • About Boyds
    • Why Boyds
    • Our Team
    • Vision and Values
    • Working at Boyds
    • Join Us
  • Services
    • Product Development
      • Due Diligence
      • Toxicology Consulting
    • Regulatory Affairs
      • Regulatory and Medical Writing
      • Toxicology Consulting
    • Clinical Operations
      • Study Start-Up
      • Site Monitoring
      • Clinical Project Management
      • Biostatistics
    • Clinical and Medical Affairs
      • Scientific and Medical Advice
      • Medical Monitoring
      • Safety and Pharmacovigilance
  • Regulatory Updates
  • Latest
    • News
    • Blogs
    • Events
  • Resources
  • Contact
Menu
  • Home
  • About
    • About Boyds
    • Why Boyds
    • Our Team
    • Vision and Values
    • Working at Boyds
    • Join Us
  • Services
    • Product Development
      • Due Diligence
      • Toxicology Consulting
    • Regulatory Affairs
      • Regulatory and Medical Writing
      • Toxicology Consulting
    • Clinical Operations
      • Study Start-Up
      • Site Monitoring
      • Clinical Project Management
      • Biostatistics
    • Clinical and Medical Affairs
      • Scientific and Medical Advice
      • Medical Monitoring
      • Safety and Pharmacovigilance
  • Regulatory Updates
  • Latest
    • News
    • Blogs
    • Events
  • Resources
  • Contact

Resources

Useful links

Regulatory Agencies
  • European Medicines Agency (EU)
  • Food and Drug Administration (US)
  • Health Canada
  • Therapeutic Goods Administration (Australia)
  • Head of Medicines Agencies
  • MHRA (UK)
Partners
  • MIAS Pharma
  • S-cubed Biometrics
  • Stratagem
  • TherapeutAix
Organisations
  • The Faculty of Pharmaceutical Medicine
  • European Society of Cell and Gene Therapy (ESCGT)
  • TOPRA
  • Parenteral Drug Association (PDA)
  • Biotechnology Industry Organisation(BIO)
  • UK Bio Industry Association (BIA)
  • World Health Organisation (WHO)
  • International Conference on Harmonisation (ICH)
  • EDQM
  • Orphaned
  • EU Clinical Trials Register
  • US Clinical Trials Register
  • Eurordis Rare disease Patient Groups

Factsheets

Click on the link below to download our latest factsheet. We will be adding more in the coming months.

  • Orphan Drug Designation (EU & UK)
  • Orphan Drug Designation (US)
  • The Clinical Trials Regulation and the Clinical Trials Information System
  • Scientific Advice US-FDA
Sign up for the latest updates
Sign Up

Speak to a member of the team today

Contact Us

Contact Us

T +44 (0)1270 270010
E info@boydconsultants.com

Twitter Linkedin

Services

  • Product Development
  • Regulatory Affairs
  • Clinical Operations
  • Clinical and Medical Affairs

Tweets

Orphan Drug Designation in the US: Why does it matter?

Read our … latest article, written by Katy Rudnick, investigating how and why small pharmas should get onboard to help develop medicines effective in the treatment of orphan diseases. https://t.co/X6g4HLDfGM

Reply on Twitter 1526851531705749506Retweet on Twitter 15268515317057495061Like on Twitter 15268515317057495062Twitter 1526851531705749506

Newsletter Sign-up

Sign up to our monthly newsletter to stay up to date with the latest news and views from Boyds.

Sign Up

Services

  • Product Development
  • Regulatory Affairs
  • Clinical Operations
  • Clinical & Medical Affairs

Contact Us

T +44 (0)1270 270010
E info@boydconsultants.com

Twitter Linkedin

Newsletter Sign-up

Sign up to our monthly newsletter to stay up to date with the latest news and views from Boyds.

Sign Up

©2022 Boyds. Boyds is a trading name of Alan Boyd Consultants Ltd. Registered in England & Wales 5395927

Privacy Policy      Contact

arrow